• Home / GORE® TAG® Thoracic Endoprosthesis /
Challenge: Advancing endovascular therapy to treat thoracic disease

Choice: GORE® TAG® Thoracic Endoprosthesis

Traditional treatment of diseases of the thoracic aorta has involved high-risk surgery resulting in long hospital stays and painful recoveries. For more than a decade, Gore has worked alongside physicians in the evolution of the GORE® TAG® Thoracic Endoprosthesis. Our collaboration has resulted in the distribution of more than 33,500 devices for the treatment of more than 20,000 patients worldwide1.

The GORE® TAG® Device has an elegantly simple design comprised of an ePTFE graft with an outer self-expanding nitinol support structure to combine both device flexibility and material durability. The function of the endoprosthesis is to internally reline the thoracic aorta and isolate the diseased segment from blood circulation. The GORE® TAG® Device has remained the leading option for less invasive treatment of thoracic aneurysms and lesions with a proven safety record, which is supported by more than ten years of worldwide clinical data. The next generation Conformable GORE® TAG® Device was engineered for flexibility and conformability in tortuous anatomy to meet the needs of individual patients.

The next generation Conformable GORE® TAG® Device design enhancements include a modified stent frame, repositioned gold bands, and optimized graft film layers for improved conformability in tortuous anatomies. The device is available in diameters of 21 - 45 mm, allowing for the treatment of patients with aortic diameters of 16 - 42 mm. Tapered device configurations are also available. In addition, the device now offers clinicians a modified device delivery catheter that is designed for enhanced trackability and deliverability to the target. The modified GORE® TAG® Device delivery catheter is a simple, single-step deployment system engineered to optimize placement and control. The novel sheathless delivery catheter provides flexibility for navigating tortuous anatomy and low deployment forces.

1 33,500 devices distributed worldwide divided by 1.7 devices per patient = more than 20,000 patients treated

Find out more about the entire
family of Aortic Accessories